New Jersey A 2168: Permits patients to indicate that they should not be prescribed opiates and certain other controlled substances in prescription monitoring program information.

Status: Introduced in the Assembly, Referred to Assembly Health and Senior Services Committee (as of 2018-01-29)

State: New Jersey · Session: 218 · Bill: A 2168

Subjects: DRUG ABUSE, PHARMACEUTIC

Sponsors: Armato, John, Mazzeo, Vincent

View New Jersey A 2168 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.